Nomoto K, Yokokura T, Yoshikai Y, Mitsuyama M, Nomoto K
Yakult Central Institute for Microbiological Research, Tokyo, Japan.
Can J Microbiol. 1991 Mar;37(3):244-7. doi: 10.1139/m91-037.
A single administration of fluorouracil (5-FU), a well-used cancer chemotherapeutic agent, at high doses (338-800 mg/kg) to specific pathogen free mice induced a lethal infection with Escherichia coli. The infection was manifested in all the mice treated with 5-FU 7-14 days after administration of the drug, when the number of E. coli in liver reached levels ranging from 10(8) to 10(10) colony-forming units, and the type of the infecting bacteria was limited to E. coli. The infection was accompanied with the increase in the population levels of E. coli in the intestinal tract which reached levels about 10(3) to 10(4) times as high as those of normal mice. Administration of tegafur, a less toxic derivative of 5-FU, to mice at a lethal dose of 1280 mg/kg induced infection with E. coli similar to that induced by 5-FU. Multiple administration of both streptomycin sulfate and cephalothin to mice after treatment with 5-FU protected the mice completely from the lethal infection induced by 5-FU, suggesting that the lethality of 5-FU was due to indigenous bacterial infection.
向无特定病原体的小鼠单次高剂量(338 - 800毫克/千克)给予常用的癌症化疗药物氟尿嘧啶(5 - FU)会引发大肠杆菌致死性感染。在给药后7至14天,所有接受5 - FU治疗的小鼠均出现感染,此时肝脏中的大肠杆菌数量达到10⁸至10¹⁰集落形成单位的水平,且感染的细菌类型仅限于大肠杆菌。感染伴随着肠道中大肠杆菌种群水平的增加,其达到的水平约为正常小鼠的10³至10⁴倍。以1280毫克/千克的致死剂量向小鼠给予替加氟(5 - FU的低毒衍生物)会引发与5 - FU诱导的类似的大肠杆菌感染。在用5 - FU治疗后对小鼠多次给予硫酸链霉素和头孢噻吩可使小鼠完全免受5 - FU诱导的致死性感染,这表明5 - FU的致死性是由于原发性细菌感染所致。